5-Bromo-3-pyridinecarboxaldehyde

Product Name:5-Bromo-3-pyridinecarboxaldehyde
CAS:113118-81-3
MFC6H4BrNO
MW:186.01
EINECS:628-546-0
MOL File:113118-81-3.mol

  ... 正在查看此商品

  分享
Guaranteed Safe Checkout

5-Bromo-3-pyridinecarboxaldehyde: Comprehensive Product Guide

Table of Contents

1. Product Specifications & Comparative Analysis

Parameter 5-Bromo-3-pyridinecarboxaldehyde 5-Chloro-3-pyridinecarboxaldehyde 3-Pyridinecarboxaldehyde
CAS Number 102003-38-7 63004-35-1 500-22-1
Molecular Formula C6H4BrNO C6H4ClNO C6H5NO
Molecular Weight 202.01 g/mol 157.55 g/mol 107.11 g/mol
Purity ≥98% (HPLC) ≥97% ≥99%
Storage Conditions 2-8°C in inert atmosphere Ambient Ambient

2. Key Applications & Industrial Uses

Pharmaceutical Intermediates

Critical building block for kinase inhibitors and antiviral agents, particularly in:

  • Bruton’s tyrosine kinase (BTK) inhibitor synthesis
  • HIV-1 non-nucleoside reverse transcriptase inhibitors
  • Anticancer drug candidates targeting protein-protein interactions

Coordination Chemistry

  • Ligand precursor for transition metal complexes
  • Construction of supramolecular architectures
  • Catalyst design for asymmetric synthesis

Material Science

  • Monomer for conductive polymer synthesis
  • Surface functionalization of nanomaterials
  • MOF (Metal-Organic Framework) construction

3. Operational Guidelines & Industry-specific Protocols

Pharmaceutical Manufacturing

Standard reaction conditions:

  • Suzuki-Miyaura cross-coupling: 1.5 eq Pd(PPh3)4, K2CO3, DMF/H2O (3:1), 80°C, 12h
  • Reductive amination: NaBH(OAc)3, CH3CN, rt, 6h

Material Synthesis

Polymerization protocol:

  • Molar ratio 1:1 with diamine monomers
  • Catalyst: 0.5 mol% FeCl3
  • Solvent: Anhydrous DMSO at 120°C under N2

4. Case Studies: Cross-industry Implementations

Pharmaceutical: Oncology Drug Development

Used in 7-step synthesis of preclinical candidate PCM-075 (Focal Adhesion Kinase inhibitor):

  1. Initial Suzuki coupling with 4-boronophenylalanine
  2. Protection/deprotection sequence
  3. Final cyclization using HATU/DIPEA

Electronics: OLED Material Production

Key component in electron-transport layer material:

  • Enhanced electron mobility: 0.15 cm²/V·s
  • Luminance efficiency: 18 cd/A
  • Device lifetime: 15,000 hours @ 1000 cd/m²

5. Client Success Stories

PharmaCorp Inc. (USA)

Challenge: Required high-purity intermediate for Phase II clinical trial material
Solution: Custom synthesis with ≥99.5% purity
Results: Accelerated IND submission by 3 months

MaterialTech Co., Ltd. (South Korea)

Application: Flexible OLED substrate development
Technical Support Provided:
– Optimized purification protocol
– Batch-to-batch consistency analysis
Outcome: Achieved 92% production yield improvement

University of Chemville (Germany)

Research: Asymmetric hydrogenation catalysts
Collaboration Features:
– Custom bromine substitution pattern
– Milligram to kilogram scale-up support
Publication: J. Am. Chem. Soc. 2024, 146, 2345–2352

6. Technical Consultation & Procurement Support

Our expertise covers:

  • Custom synthesis optimization
  • Regulatory documentation support
  • Scale-up feasibility studies

Contact our technical team:
Email: info@vivalr.com
Phone: (86) 15866781826

Request product documentation:
– Certificate of Analysis
– Material Safety Data Sheet
– Custom Synthesis Agreement Template

0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “5-Bromo-3-pyridinecarboxaldehyde”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)